Kava.

Both kava's kavalactones and valerian's valerenic acid influence GABA-A receptor signaling, the main inhibitory brake on neuronal firing, so pairing them can stack GABAergic tone and add to a calm, drowsy state. Because that sedation is additive, the combination is one to approach with restraint rather than for extra dosing.

Passionflower flavonoids and kava's kavalactones both act on GABA-A signaling to support a settled, relaxed state before rest, and the two have a long history of being formulated together for that reason. The calming effects are additive, so combined use tilts toward more sedation.

Chamomile apigenin binds the benzodiazepine site on the GABA-A receptor, the same receptor complex kavalactones modulate allosterically. The effect on central calming is additive.

Lemon balm inhibits GABA transaminase so synaptic GABA persists longer, while kavalactones increase the receptor's response to whatever GABA is present. The two act on opposite ends of the same synapse.

Honokiol and magnolol are positive allosteric modulators at GABA-A receptors, overlapping directly with kavalactone action. Central calming effects add, which is the honest framing for stacking them.

Oxidative metabolism of kavalactones generates quinone-type intermediates that are cleared by glutathione conjugation. NAC supplies cysteine, the rate-limiting amino acid for glutathione synthesis, so it supports the clearance route rather than the kavalactone effect.

St John's wort hyperforin induces CYP3A4 and P-glycoprotein while kavalactones inhibit several CYP enzymes including 1A2, 2C9 and 2E1. Each changes how fast the other is cleared, so the combination makes exposure unpredictable in both directions.

Melatonin acts through MT1 and MT2 receptors on circadian timing while kavalactones modulate GABA-A signalling. Taken together the sedating effect is additive, which is the reason evening blends pair them and also the reason next-morning grogginess is the common complaint. Anyone driving or operating machinery should account for the combined effect.

L-theanine raises alpha-band cortical activity and modulates glutamatergic tone; kavalactones act as positive modulators at GABA-A sites. The two are commonly formulated together for that complementary action. The combination has not been isolated in a trial that a source reports.

Kavalactones act as positive allosteric modulators at GABA-A receptors, meaning they amplify the response to GABA rather than opening the channel themselves. Supplemental GABA crosses the blood-brain barrier poorly, so most of the interaction is peripheral or enteric. The receptor relationship is established even where the supplemental route is uncertain.

Glycine is an inhibitory neurotransmitter in its own right at glycine receptors and has been studied for sleep onset. Combined with a GABA-A modulator the inhibitory tone stacks. Both are commonly present in the same evening formulation.

Magnesium blocks the NMDA channel pore in a voltage-dependent way, damping excitatory signalling from a different direction than a GABA-A modulator. Evening formulations pair it with kava for that reason. The additive sedation is a formulation expectation rather than a trial result.

Tryptophan is the precursor for serotonin and downstream melatonin, so it feeds a pathway kava does not touch directly. Combining a precursor route with a receptor-modulating route stacks the sedating effect. Anyone taking a serotonergic medicine should not add tryptophan without medical advice.

5-HTP bypasses the rate-limiting hydroxylation step and raises serotonin synthesis directly. Paired with a GABA-A modulator the sedating effect adds. This pairing carries a real interaction risk with serotonergic medicines and is not a casual stack.

Caffeine antagonises adenosine receptors and raises arousal, which opposes the calming action of kavalactones. Taking both produces a muddled subjective state rather than cancelling cleanly, since the two act on unrelated receptor systems. Timing them apart is the sensible approach.

Kavalactones are poorly water soluble, which is why traditional preparation kneads the root in water with an emulsifying fat and why modern liquids use a lipid carrier. An MCT vehicle keeps the lactones dispersed and available for micellar uptake. This is formulation chemistry with a long practical record.

Phospholipid emulsifiers disperse lipophilic kavalactones into fine droplets that mix with bile micelles more readily. Liquid and powder formats use lecithin for exactly this. It changes dispersion, not the pharmacology of the lactones themselves.

Phosphatidylcholine complexes are used across botanical formulation to carry poorly soluble constituents into micelles. Applied to a kavalactone extract the rationale is dispersion, not a change in receptor activity. Whether it changes blood levels in people is not something a source states for kava specifically.

Piperine slows both oxidative and glucuronidation clearance, which raises exposure to co-dosed compounds that use those routes. Kavalactones are cleared partly by CYP enzymes and by glucuronidation, so adding piperine raises exposure in a way that is hard to predict. That is a caution to state rather than a benefit to formulate around.

Glutathione conjugation is one of the routes that handles reactive intermediates from botanical metabolism, and hepatic glutathione is depletable. This is why glutathione and its precursors are discussed alongside kava rather than as an effect of kava. The relationship is mechanistic and is not a claim that any pairing changes an outcome.

Silymarin has documented effects on drug-metabolising enzymes, so co-dosing it with a botanical cleared by those enzymes changes exposure in an unpredictable direction. Blends pair the two on a hepatic-support rationale. The enzyme interaction is the part that is established; the pairing's benefit is not.

High-dose green tea extract has its own documented hepatic tolerability literature, including work on COMT and UGT genotype effects. Stacking two concentrated botanical extracts that both go through hepatic conjugation is worth flagging rather than formulating. This is a caution about combined load, not a claim about either ingredient alone.

Ashwagandha and kava appear together in evening and stress-support formulations. Both carry sedating potential, so the subjective effect adds. Each has its own tolerability literature and stacking two botanicals does not average their risk profiles.

Hops is a long-standing component of sedative herbal blends and is frequently placed alongside kava and valerian. The pairing is formulation convention with additive subjective sedation. No trial isolates the two together.